Me-DL-Ser-Arg-DL-Arg-Arg-DL-Arg-Arg-DL-Arg-Gly-NH2

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: Me-DL-Ser-Arg-DL-Arg-Arg-DL-Arg-Arg-DL-Arg-Gly-NH2
• 英文别名: N-(2-amino-2-oxoethyl)-5-(diaminomethylideneamino)-2-[[(2S)-5-(diaminomethylideneamino)-2-[[5-(diaminomethylideneamino)-2-[[(2S)-5-(diaminomethylideneamino)-2-[[5-(diaminomethylideneamino)-2-[[(2S)-5-(diaminomethylideneamino)-2-[[3-hydroxy-2-(methylamino)propanoyl]amino]pentanoyl]amino]pentanoyl]amino]pentanoyl]amino]pentanoyl]amino]pentanoyl]amino]pentanamide
• 化学式: C₄₂H₈₅N₂₇O₉
• 分子量: 1112.3
• InChiKey: STLPNQHKGNPQQC-VBOFDEDDSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -11.3
• 重原子数：
  78
• 可旋转键数：
  41
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.67
• 拓扑面积：
  665
• 氢给体数：
  22
• 氢受体数：
  16

文献信息

• HYALURONIC ACID CONTAINING COMPOSITIONS FOR TREATMENT OF WOUNDS, SCARS, POST-SURGICAL ADHESION FORMATION
  申请人：PERGAMUM AB

  公开号：US20140349949A1

  公开（公告）日：2014-11-27

  The present invention relates to pharmaceutical compositions enhancing the therapeutic effect of biologically active peptides, especially peptides derived from human lactoferrin. The compositions are useful for the treatment and/or prevention of wounds, scars, and post surgical adhesions.
• HYALURONIC ACID CONTAINING COMPOSITIONS FOR PREVENTION OF THE FORMATION OF POST-SURGICAL SCARS AND POST-SURGICAL ADHESIONS
  申请人：PERGAMUM AB

  公开号：US20180200341A1

  公开（公告）日：2018-07-19

  The present invention relates to pharmaceutical compositions enhancing the therapeutic effect of biologically active peptides, especially peptides derived from human lactoferrin. The compositions are useful for the treatment and/or prevention of wounds, scars, and post surgical adhesions.
• US8815812B2
  申请人：——

  公开号：US8815812B2

  公开（公告）日：2014-08-26
• US9878019B2
  申请人：——

  公开号：US9878019B2

  公开（公告）日：2018-01-30